6MP adherence in a multiracial cohort of children with acute lymphoblastic leukemia: a Children's Oncology Group studyRavi Bhatia, Mary V. Relling, Wendy Landier et al.|Blood|2014Cited by 204
Comparison of self-report and electronic monitoring of 6MP intake in childhood ALL: a Children’s Oncology Group studyWendy Landier, Smita Bhatia, Yanjun Chen et al.|Blood|2017Cited by 46
High Intra-Individual Variability In Systemic Exposure To 6 Mercaptopurine (6MP) In Children With Acute Lymphoblastic Leukemia (ALL) Contributes To ALL Relapse: Results From a Children’s Oncology Group (COG) Study (AALL03N1)Ravi Bhatia, Mary V. Relling, Wendy Landier et al.|Blood|2013Cited by 7
6-Mercaptopurine (6MP) Intake during Maintenance for Childhood Acute Lymphoblastic Leukemia (ALL) - a Comparison of Self-Report and Electronic Monitoring: A Report from the Children's Oncology Group (COG) Study AALL03N1Wendy Landier, Smita Bhatia, Yanjun Chen et al.|Blood|2015Cited by 4
Nonadherence to Oral 6-Mercaptopurine (6MP) in a Multi-Ethnic Cohort of Children with Acute Lymphoblastic Leukemia (ALL) and Its Impact On Relapse – a Children's Oncology Group (COG) Study (AALL03N1)Ravi Bhatia, Mary V. Relling, Wendy Landier et al.|Blood|2012Cited by 3